A citation-based method for searching scientific literature

Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington, James O'Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip Rustagi, Catherine Y C Ng, Mark A Kay, Junfang Zhou, Yunyu Spence, Christopher L Morton, James Allay, John Coleman, Susan Sleep, John M Cunningham, Deokumar Srivastava, Etiena Basner-Tschakarjan, Federico Mingozzi, Katherine A High, John T Gray, Ulrike M Reiss, Arthur W Nienhuis, Andrew M Davidoff. N Engl J Med 2011
Times Cited: 1172







List of co-cited articles
1097 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
749
44

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Catherine S Manno, Glenn F Pierce, Valder R Arruda, Bertil Glader, Margaret Ragni, John J Rasko, Margareth C Ozelo, Keith Hoots, Philip Blatt, Barbara Konkle,[...]. Nat Med 2006
44

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
362
42

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
353
33

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
K John Pasi, Savita Rangarajan, Nina Mitchell, Will Lester, Emily Symington, Bella Madan, Michael Laffan, Chris B Russell, Mingjin Li, Glenn F Pierce,[...]. N Engl J Med 2020
152
30

Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig,[...]. Blood 2018
156
26

Adeno-associated virus vector as a platform for gene therapy delivery.
Dan Wang, Phillip W L Tai, Guangping Gao. Nat Rev Drug Discov 2019
527
26

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Sylvie Boutin, Virginie Monteilhet, Philippe Veron, Christian Leborgne, Olivier Benveniste, Marie Françoise Montus, Carole Masurier. Hum Gene Ther 2010
539
22

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.
Jerry R Mendell, Samiah Al-Zaidy, Richard Shell, W Dave Arnold, Louise R Rodino-Klapac, Thomas W Prior, Linda Lowes, Lindsay Alfano, Katherine Berry, Kathleen Church,[...]. N Engl J Med 2017
966
21

CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Federico Mingozzi, Marcela V Maus, Daniel J Hui, Denise E Sabatino, Samuel L Murphy, John E J Rasko, Margaret V Ragni, Catherine S Manno, Jurg Sommer, Haiyan Jiang,[...]. Nat Med 2007
487
21

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.
Roberto Calcedo, Luk H Vandenberghe, Guangping Gao, Jianping Lin, James M Wilson. J Infect Dis 2009
466
18

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
Christian Leborgne, Elena Barbon, Jeffrey M Alexander, Hayley Hanby, Sandrine Delignat, Daniel M Cohen, Fanny Collaud, Saghana Muraleetharan, Dan Lupo, Joseph Silverberg,[...]. Nat Med 2020
84
20

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer.
Helena Costa Verdera, Klaudia Kuranda, Federico Mingozzi. Mol Ther 2020
133
17

Emerging Issues in AAV-Mediated In Vivo Gene Therapy.
Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi. Mol Ther Methods Clin Dev 2017
348
17


Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial.
Céline Vandamme, Oumeya Adjali, Federico Mingozzi. Hum Gene Ther 2017
116
15

Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
C Li, N Narkbunnam, R J Samulski, A Asokan, G Hu, L J Jacobson, M J Manco-Johnson, P E Monahan. Gene Ther 2012
132
15

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
Barbara A Konkle, Christopher E Walsh, Miguel A Escobar, Neil C Josephson, Guy Young, Annette von Drygalski, Scott W J McPhee, R Jude Samulski, Ivan Bilic, Maurus de la Rosa,[...]. Blood 2021
30
50

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
Amine Meliani, Florence Boisgerault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Severine Charles,[...]. Nat Commun 2018
114
14

Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.
Haiyan Jiang, Linda B Couto, Susannah Patarroyo-White, Tongyao Liu, Dea Nagy, Joseph A Vargas, Shangzhen Zhou, Ciaran D Scallan, Jurg Sommer, Sharmila Vijay,[...]. Blood 2006
220
14

Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
Lindsey A George, Margaret V Ragni, John E J Rasko, Leslie J Raffini, Benjamin J Samelson-Jones, Margareth Ozelo, Maria Hazbon, Alexa R Runowski, Jennifer A Wellman, Katie Wachtel,[...]. Mol Ther 2020
47
29

Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction.
Wenwei Shao, Lauriel F Earley, Zheng Chai, Xiaojing Chen, Junjiang Sun, Ting He, Meng Deng, Matthew L Hirsch, Jenny Ting, R Jude Samulski,[...]. JCI Insight 2018
37
35

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Jean-Charles Nault, Shalini Datta, Sandrine Imbeaud, Andrea Franconi, Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati, Benjamin Verret, Jean-Frédéric Blanc,[...]. Nat Genet 2015
272
13

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
Guang-Ping Gao, Mauricio R Alvira, Lili Wang, Roberto Calcedo, Julie Johnston, James M Wilson. Proc Natl Acad Sci U S A 2002
13

Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Christian Hinderer, Nathan Katz, Elizabeth L Buza, Cecilia Dyer, Tamara Goode, Peter Bell, Laura K Richman, James M Wilson. Hum Gene Ther 2018
302
13


The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.
Ashley T Martino, Masataka Suzuki, David M Markusic, Irene Zolotukhin, Renee C Ryals, Babak Moghimi, Hildegund C J Ertl, Daniel A Muruve, Brendan Lee, Roland W Herzog. Blood 2011
139
13

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors.
Giuseppe Ronzitti, David-Alexandre Gross, Federico Mingozzi. Front Immunol 2020
76
17

Engineering adeno-associated virus vectors for gene therapy.
Chengwen Li, R Jude Samulski. Nat Rev Genet 2020
247
13

Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.
Amit C Nathwani, Cecilia Rosales, Jenny McIntosh, Ghasem Rastegarlari, Devhrut Nathwani, Deepak Raj, Sushmita Nawathe, Simon N Waddington, Roderick Bronson, Scott Jackson,[...]. Mol Ther 2011
206
12


WFH Guidelines for the Management of Hemophilia, 3rd edition.
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel Carcao, Johnny Mahlangu, Margaret V Ragni, Jerzy Windyga,[...]. Haemophilia 2020
300
12

X-linked thrombophilia with a mutant factor IX (factor IX Padua).
Paolo Simioni, Daniela Tormene, Giulio Tognin, Sabrina Gavasso, Cristiana Bulato, Nicholas P Iacobelli, Jonathan D Finn, Luca Spiezia, Claudia Radu, Valder R Arruda. N Engl J Med 2009
197
11

Update on clinical gene therapy for hemophilia.
George Q Perrin, Roland W Herzog, David M Markusic. Blood 2019
75
14

Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Nicole K Paulk, Katja Pekrun, Erhua Zhu, Sean Nygaard, Bin Li, Jianpeng Xu, Kirk Chu, Christian Leborgne, Allison P Dane, Annelise Haft,[...]. Mol Ther 2018
92
11

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, Laetitia van Wittenberghe, Alban Vignaud, Fanny Collaud, Séverine Charles, Marcelo Simon Sola,[...]. Mol Ther Methods Clin Dev 2018
82
13

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
Dirk Grimm, Joyce S Lee, Lora Wang, Tushar Desai, Bassel Akache, Theresa A Storm, Mark A Kay. J Virol 2008
392
11

Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Randy J Chandler, Matthew C LaFave, Gaurav K Varshney, Niraj S Trivedi, Nuria Carrillo-Carrasco, Julien S Senac, Weiwei Wu, Victoria Hoffmann, Abdel G Elkahloun, Shawn M Burgess,[...]. J Clin Invest 2015
200
11

Adeno-associated virus antibody profiles in newborns, children, and adolescents.
Roberto Calcedo, Hiroki Morizono, Lili Wang, Robert McCarter, Jianping He, David Jones, Mark L Batshaw, James M Wilson. Clin Vaccine Immunol 2011
182
11

Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors.
Lili Wang, Roberto Calcedo, Peter Bell, Jianping Lin, Rebecca L Grant, Don L Siegel, James M Wilson. Hum Gene Ther 2011
127
11

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, Doyoung Lee, Samira Rabbanian, Deepak Raj, Nishil Patel, Edward G D Tuddenham, Olivier D Christophe, John H McVey,[...]. Blood 2013
179
11

CpG-depleted adeno-associated virus vectors evade immune detection.
Susan M Faust, Peter Bell, Benjamin J Cutler, Scott N Ashley, Yanqing Zhu, Joseph E Rabinowitz, James M Wilson. J Clin Invest 2013
119
11

Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.
Marianna Hösel, Mathias Broxtermann, Hanna Janicki, Knud Esser, Silke Arzberger, Pia Hartmann, Sonja Gillen, Jörg Kleeff, Dirk Stabenow, Margarete Odenthal,[...]. Hepatology 2012
94
11

A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.
Virginie Monteilhet, Samir Saheb, Sylvie Boutin, Christian Leborgne, Philippe Veron, Marie-Françoise Montus, Philippe Moullier, Olivier Benveniste, Carole Masurier. Mol Ther 2011
108
11

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.
Berangere Bertin, Philippe Veron, Christian Leborgne, Jack-Yves Deschamps, Sophie Moullec, Yves Fromes, Fanny Collaud, Sylvie Boutin, Virginie Latournerie, Laetitia van Wittenberghe,[...]. Sci Rep 2020
33
33

A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.
Giang N Nguyen, John K Everett, Samita Kafle, Aoife M Roche, Hayley E Raymond, Jacob Leiby, Christian Wood, Charles-Antoine Assenmacher, Elizabeth P Merricks, C Tyler Long,[...]. Nat Biotechnol 2021
78
14

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
478
10

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors.
Anita Kruzik, Damir Fetahagic, Bettina Hartlieb, Sebastian Dorn, Herwig Koppensteiner, Frank M Horling, Friedrich Scheiflinger, Birgit M Reipert, Maurus de la Rosa. Mol Ther Methods Clin Dev 2019
47
21

Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
Vedell Louis Jeune, Jakob A Joergensen, Roger J Hajjar, Thomas Weber. Hum Gene Ther Methods 2013
150
10

AAV vector integration sites in mouse hepatocellular carcinoma.
Anthony Donsante, Daniel G Miller, Yi Li, Carole Vogler, Elizabeth M Brunt, David W Russell, Mark S Sands. Science 2007
410
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.